Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.82)
# 742
Out of 4,711 analysts
71
Total ratings
35.21%
Success rate
15.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Reiterates: Buy | $75 | $28.67 | +161.60% | 9 | Dec 6, 2024 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $40 → $50 | $44.78 | +11.66% | 13 | Nov 26, 2024 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $1.59 | +843.40% | 15 | Nov 19, 2024 | |
| MURA Mural Oncology | Reiterates: Buy | $18 | $3.18 | +466.04% | 3 | Nov 14, 2024 | |
| ERAS Erasca | Reiterates: Buy | $6 | $2.54 | +136.22% | 8 | Nov 13, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.55 | +158.06% | 11 | Nov 11, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $12.79 | +212.74% | 12 | Oct 31, 2024 |
CG Oncology
Dec 6, 2024
Reiterates: Buy
Price Target: $75
Current: $28.67
Upside: +161.60%
Scholar Rock Holding
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $44.78
Upside: +11.66%
Werewolf Therapeutics
Nov 19, 2024
Reiterates: Buy
Price Target: $15
Current: $1.59
Upside: +843.40%
Mural Oncology
Nov 14, 2024
Reiterates: Buy
Price Target: $18
Current: $3.18
Upside: +466.04%
Erasca
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $2.54
Upside: +136.22%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.55
Upside: +158.06%
Day One Biopharmaceuticals
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $12.79
Upside: +212.74%